These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 31576628)
1. Clinical, pathological characteristics and outcomes of immunoglobulin A nephropathy patients with different ages. Wen Q; Rong R; Zhou Q; Tang X; Yang Q; Chen W; Yu X Nephrology (Carlton); 2020 Dec; 25(12):906-912. PubMed ID: 31576628 [TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study. Tian S; Yang X; Luo J; Guo H Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045 [TBL] [Abstract][Full Text] [Related]
3. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases. Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674 [TBL] [Abstract][Full Text] [Related]
4. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy. Wang S; Dong L; Pei G; Jiang Z; Qin A; Tan J; Tang Y; Qin W Front Immunol; 2021; 12():700224. PubMed ID: 34456912 [TBL] [Abstract][Full Text] [Related]
5. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology. Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110 [TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy. Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190 [TBL] [Abstract][Full Text] [Related]
7. A validation study of crescents in predicting ESRD in patients with IgA nephropathy. Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226 [TBL] [Abstract][Full Text] [Related]
8. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258 [TBL] [Abstract][Full Text] [Related]
9. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients. Jiang Z; Tan J; Wang S; Dong L; Han X; Tang Y; Qin W Int J Med Sci; 2021; 18(13):2964-2970. PubMed ID: 34220324 [No Abstract] [Full Text] [Related]
10. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome. Han X; Xiao Y; Tang Y; Zheng X; Anwar M; Qin W Clin Exp Med; 2019 Nov; 19(4):479-486. PubMed ID: 31542837 [TBL] [Abstract][Full Text] [Related]
11. Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy. Wu J; Hu Z; Wang Y; Hu D; Yang Q; Li Y; Dai W; Zhu F; Yang J; Wang M; Zhu H; Liu L; He X; Han M; Yao Y; Pei G; Zeng R; Xu G Histopathology; 2021 May; 78(6):882-895. PubMed ID: 33336446 [TBL] [Abstract][Full Text] [Related]
12. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L; Cai K; Wang K; Luo Q J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240 [TBL] [Abstract][Full Text] [Related]
13. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial. Li S; Li JP Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076 [TBL] [Abstract][Full Text] [Related]
14. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases. Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247 [TBL] [Abstract][Full Text] [Related]
15. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy. Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366 [TBL] [Abstract][Full Text] [Related]
16. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study. Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease. Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358 [TBL] [Abstract][Full Text] [Related]
18. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy. Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of IgA nephropathy patients with different proportions of crescents. Zhang W; Zhou Q; Hong L; Chen W; Yang S; Yang Q; Chen W; Yu X Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of the systemic immune inflammation index in patients with IgA nephropathy. Zhai Y; Sun S; Zhang W; Tian H Ren Fail; 2024 Dec; 46(2):2381613. PubMed ID: 39039867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]